CELL-MEDIATED IMMUNITY TO EPSTEIN-BARR VIRUS IN NASOPHARYNGEAL CARCINOMA
- 21 April 1979
- journal article
- other
- Published by Elsevier in The Lancet
- Vol. 313 (8121) , 884-885
- https://doi.org/10.1016/s0140-6736(79)91309-6
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- A comparison of the prognostic value of antibody-dependent lymphocyte cytotoxicity and other ebv antibody assays in Chinese patients with nasopharyngeal carcinomaInternational Journal of Cancer, 1979
- PROSPECTIVE STUDY OF EPSTEIN-BARR VIRUS ANTIBODY TITRES AND SURVIVAL IN PATIENTS WITH NASOPHARYNGEAL CARCINOMAThe Lancet, 1977
- Impaired general cell‐mediated immune functions in vivo and in vitro in patients with nasopharyngeal carcinomaInternational Journal of Cancer, 1976
- The genetics of hereditary angioedema: A hypothesisClinical Genetics, 1973
- Genetically determined heterogeneity of the C1 esterase inhibitor in patients with hereditary angioneurotic edemaJournal of Clinical Investigation, 1971
- Induction of Cellular DNA Synthesis in Human Leucocytes by Epstein–Barr VirusNature, 1971
- Epstein–Barr Virus in Burkitt's Lymphoma and Nasopharyngeal Carcinoma: EBV DNA in Biopsies of Burkitt Tumours and Anaplastic Carcinomas of the NasopharynxNature, 1970
- A biochemical abnormality in hereditary angioneurotic edemaThe American Journal of Medicine, 1963